Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Serum levels of cytokines and biomarkers for inflammation and immune activation, and HIV-associated non-Hodgkin B-cell lymphoma risk.

Vendrame E, Hussain SK, Breen EC, Magpantay LI, Widney DP, Jacobson LP, Variakojis D, Knowlton ER, Bream JH, Ambinder RF, Detels R, Martínez-Maza O.

Cancer Epidemiol Biomarkers Prev. 2014 Feb;23(2):343-9. doi: 10.1158/1055-9965.EPI-13-0714. Epub 2013 Nov 12.

2.

B-cell stimulatory cytokines and markers of immune activation are elevated several years prior to the diagnosis of systemic AIDS-associated non-Hodgkin B-cell lymphoma.

Breen EC, Hussain SK, Magpantay L, Jacobson LP, Detels R, Rabkin CS, Kaslow RA, Variakojis D, Bream JH, Rinaldo CR, Ambinder RF, Martinez-Maza O.

Cancer Epidemiol Biomarkers Prev. 2011 Jul;20(7):1303-14. doi: 10.1158/1055-9965.EPI-11-0037. Epub 2011 Apr 28.

3.

Serum biomarkers of immune activation and subsequent risk of non-hodgkin B-cell lymphoma among HIV-infected women.

Hussain SK, Hessol NA, Levine AM, Breen EC, Anastos K, Cohen M, D'Souza G, Gustafson DR, Silver S, Martínez-Maza O.

Cancer Epidemiol Biomarkers Prev. 2013 Nov;22(11):2084-93. doi: 10.1158/1055-9965.EPI-13-0614. Epub 2013 Sep 17.

4.

Serum levels of the chemokine CXCL13, genetic variation in CXCL13 and its receptor CXCR5, and HIV-associated non-hodgkin B-cell lymphoma risk.

Hussain SK, Zhu W, Chang SC, Breen EC, Vendrame E, Magpantay L, Widney D, Conn D, Sehl M, Jacobson LP, Bream JH, Wolinsky S, Rinaldo CR, Ambinder RF, Detels R, Zhang ZF, Martínez-Maza O.

Cancer Epidemiol Biomarkers Prev. 2013 Feb;22(2):295-307. doi: 10.1158/1055-9965.EPI-12-1122. Epub 2012 Dec 18.

5.

Circulating mediators of inflammation and immune activation in AIDS-related non-hodgkin lymphoma.

Nolen BM, Breen EC, Bream JH, Jenkins FJ, Kingsley LA, Rinaldo CR, Lokshin AE.

PLoS One. 2014 Jun 12;9(6):e99144. doi: 10.1371/journal.pone.0099144. eCollection 2014.

6.

Effect of highly active antiretroviral therapy on biomarkers of B-lymphocyte activation and inflammation.

Regidor DL, Detels R, Breen EC, Widney DP, Jacobson LP, Palella F, Rinaldo CR, Bream JH, Martínez-Maza O.

AIDS. 2011 Jan 28;25(3):303-14. doi: 10.1097/QAD.0b013e32834273ad.

7.

Serum microRNAs in HIV-infected individuals as pre-diagnosis biomarkers for AIDS-NHL.

Thapa DR, Hussain SK, Tran WC, Dʼsouza G, Bream JH, Achenback CJ, Ayyavoo V, Detels R, Martínez-Maza O.

J Acquir Immune Defic Syndr. 2014 Jun 1;66(2):229-37. doi: 10.1097/QAI.0000000000000146.

8.

TLR2-activated B cells are phenotypically similar to the abnormal circulating B cells seen preceding the diagnosis of AIDS-related NHL diagnosis.

Guo Y, Siewe B, Epeldegui M, Detels R, Landay AL, Martínez-Maza O.

J Acquir Immune Defic Syndr. 2013 Oct 1;64(2):204-10. doi: 10.1097/QAI.0b013e31829d4d50.

9.

Elevated serum soluble CD30 precedes the development of AIDS-associated non-Hodgkin's B cell lymphoma.

Breen EC, Fatahi S, Epeldegui M, Boscardin WJ, Detels R, Martínez-Maza O.

Tumour Biol. 2006;27(4):187-94. Epub 2006 Apr 27.

PMID:
16651853
10.

Predictive Value of Cytokines and Immune Activation Biomarkers in AIDS-Related Non-Hodgkin Lymphoma Treated with Rituximab plus Infusional EPOCH (AMC-034 trial).

Epeldegui M, Lee JY, Martínez AC, Widney DP, Magpantay LI, Regidor D, Mitsuyasu R, Sparano JA, Ambinder RF, Martínez-Maza O.

Clin Cancer Res. 2016 Jan 15;22(2):328-36. doi: 10.1158/1078-0432.CCR-14-0466. Epub 2015 Sep 17.

11.

Cytokines in serum in relation to future non-Hodgkin lymphoma risk: evidence for associations by histologic subtype.

Edlefsen KL, Martínez-Maza O, Madeleine MM, Magpantay L, Mirick DK, Kopecky KJ, LaCroix AZ, De Roos AJ.

Int J Cancer. 2014 Aug 15;135(4):913-22. doi: 10.1002/ijc.28724. Epub 2014 Feb 3.

12.

Circulating serum free light chains as predictive markers of AIDS-related lymphoma.

Landgren O, Goedert JJ, Rabkin CS, Wilson WH, Dunleavy K, Kyle RA, Katzmann JA, Rajkumar SV, Engels EA.

J Clin Oncol. 2010 Feb 10;28(5):773-9. doi: 10.1200/JCO.2009.25.1322. Epub 2010 Jan 4.

13.

Aberrant expression of CD27 and soluble CD27 (sCD27) in HIV infection and in AIDS-associated lymphoma.

Widney D, Gundapp G, Said JW, van der Meijden M, Bonavida B, Demidem A, Trevisan C, Taylor J, Detels R, Martínez-Maza O.

Clin Immunol. 1999 Nov;93(2):114-23.

PMID:
10527687
14.

B-cell stimulation and prolonged immune deficiency are risk factors for non-Hodgkin's lymphoma in people with AIDS.

Grulich AE, Wan X, Law MG, Milliken ST, Lewis CR, Garsia RJ, Gold J, Finlayson RJ, Cooper DA, Kaldor JM.

AIDS. 2000 Jan 28;14(2):133-40.

PMID:
10708283
15.

Non-hodgkin lymphoma and circulating markers of inflammation and adiposity in a nested case-control study: the multiethnic cohort.

Conroy SM, Maskarinec G, Morimoto Y, Franke AA, Cooney RV, Wilkens LR, Goodman MT, Hernadez BY, Le Marchand L, Henderson BE, Kolonel LN.

Cancer Epidemiol Biomarkers Prev. 2013 Mar;22(3):337-47. doi: 10.1158/1055-9965.EPI-12-0947. Epub 2013 Jan 8.

16.

Serum interleukin-10 in acquired immunodeficiency syndrome lymphoma patients. Seroco-Hemoco Study Group.

Edelman L, Deveau C, Raphael M, Monchatre E, Gabarre J, Deville-Chabrol A, Pialoux G, Emilie D, Joab I, Galanaud P.

Eur Cytokine Netw. 1996 Dec;7(4):785-91.

PMID:
9010682
17.

Circulating cytokines and risk of B-cell non-Hodgkin lymphoma: a prospective study.

Gu Y, Shore RE, Arslan AA, Koenig KL, Liu M, Ibrahim S, Lokshin AE, Zeleniuch-Jacquotte A.

Cancer Causes Control. 2010 Aug;21(8):1323-33. doi: 10.1007/s10552-010-9560-3. Epub 2010 Apr 7.

18.

Multiplex analysis of blood cytokines as a prognostic tool in HIV related non-Hodgkin lymphoma patients: a potential role of interleukin-7.

Bortolin MT, Tedeschi R, Bidoli E, Zanussi S, Pratesi C, Vaccher E, Tirelli U, De Paoli P.

Cytokine. 2012 Oct;60(1):90-5. doi: 10.1016/j.cyto.2012.06.022. Epub 2012 Jul 12.

PMID:
22795293
19.

Serum soluble CD23 level correlates with subsequent development of AIDS-related non-Hodgkin's lymphoma.

Schroeder JR, Saah AJ, Hoover DR, Margolick JB, Ambinder RF, Martinez-Maza O, Breen EC, Jacobson LP, Variakojis D, Rowe DT, Armenian HK.

Cancer Epidemiol Biomarkers Prev. 1999 Nov;8(11):979-84.

20.

Increased level of stromal cell-derived factor-1 mRNA in peripheral blood mononuclear cells from children with AIDS-related lymphoma.

Sei S, O'Neill DP, Stewart SK, Yang Q, Kumagai M, Boler AM, Adde MA, Zwerski SL, Wood LV, Venzon DJ, Magrath IT.

Cancer Res. 2001 Jul 1;61(13):5028-37.

Supplemental Content

Support Center